International Stem Cell ISCO
OTC ISCO
$0.15 -0.02 (-11.76%)
At close: Oct 22, 2026 · 4:00 PM EDT

International Stem Cell (ISCO) Dividends Paid - Common and Prefferd (2010 - 2012)

Updated

Analysis

International Stem Cell (ISCO) Dividends Paid - Common and Prefferd (2010 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div Paid (Total) (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 1.55 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 3.23 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.07 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.14 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 2.87 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 6.58 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.36 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.03 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 2.45 Bn
10 International Stem Cell 1.20 Mn -2.77 Mn 1.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 64,000.00
Jun 30, 2012 65,000.00
Mar 31, 2012 108,000.00
Dec 31, 2011 107,000.00
Sep 30, 2011 109,000.00
Jun 30, 2011 107,000.00
Mar 31, 2011 107,000.00
Dec 31, 2010 308,673.00
Sep 30, 2010 14,300.00
API Access

International Stem Cell Dividends Paid - Common and Prefferd API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-paid-common-and-prefferd&ticker=ISCO&period=max&api_key=YOUR_API_KEY